Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
BioMed Ventures: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
BioMed Ventures
BioMed Ventures
Active
Website
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Sep 1, 2021
Fauna Bio
$9.0M Seed
Lifeforce Capital
Bija Ventures
,
Arcadia Science
,
Boom Capital
,
Pacific 8 Ventures
,
True Ventures
,
Vibe Capital
May 1, 2020
Amplyx Pharmaceuticals
$53.0M Series C
Sofinnova Ventures
Abingworth
,
Deerfield Management
,
Frazier Healthcare Partners
, Ed Mathers
,
New Enterprise Associates
,
RiverVest
,
3x5 Partners
,
Adage Capital Management
,
Arix Bioscience
,
Lundbeckfond Ventures
,
Pappas Capital
,
Pfizer
,
RiverVest Venture Partners
Jul 1, 2018
Compass Therapeutics
$49.0M Series A
Carl Gordon
Atlas Venture
,
F-Prime Capital Partners
,
Alexandria Venture Investments
, Biomatics Capital
,
Borealis Ventures
, Cowen Healthcare Investments
, F-Prime Capital
,
Thiel Capital
,
Ulysses Diversified Holdings
Jan 2, 2018
AEGEA Medical
$40.0M Other Equity
Sam Chawla
Alloy Ventures
,
Delphi Ventures
, Medtronic
,
Solas BioVentures
Jul 1, 2017
Amplyx Pharmaceuticals
$67.0M Series C
Anand Mehra
Abingworth
,
Deerfield Management
,
Frazier Healthcare Partners
, Ed Mathers
,
New Enterprise Associates
,
RiverVest
, Mark Chin
, Johan Kördel
,
Pappas Capital
,
RiverVest Venture Partners
Jul 1, 2017
Effector Therapeutics
$39.0M Series C
—
Sofinnova Investments
, AbbVie Ventures
,
Abingworth
,
Alexandria Venture Investments
, Astellas Venture Management
,
Novartis
,
Sectoral Asset Management
,
SR One
,
The Column Group
,
U.S. Venture Partners
Jul 1, 2017
NeuroVia
$14.0M Series A
Sanofi Ventures
,
Novartis
Enso Ventures
Nov 1, 2015
Amplyx Pharmaceuticals
$41.0M Series B
Niall O'Donnell
Abingworth
,
Deerfield Management
,
Frazier Healthcare Partners
, Ed Mathers
,
New Enterprise Associates
,
RiverVest
Aug 1, 2015
Syndax Pharmaceuticals
$80.0M Series C
Delos
, Fidelity Management & Research Company
aMoon Fund
,
Domain Associates
, InterWest
,
Osage University Partners
,
T1D Fund
,
Vivo Capital
,
Arrowpoint Partners
,
Cormorant Asset Management
,
EcoR1 Capital
,
Forward Ventures
,
Greenwood Capital
,
Jennison Associates
,
MPM Capital
,
OrbiMed
,
RusnanoMedInvest
,
Tavistock Group
Jul 1, 2015
AnaptysBio
$40.0M Series D
—
Frazier Healthcare Partners
,
Versant Ventures
, BVF Partners
,
Cormorant Asset Management
, HBM Healthcare Investments
,
Longwood Capital Partners
, Novo Holdings
May 4, 2015
AEGEA Medical
$36.0M Series C
—
Alloy Ventures
, Covidien
,
Delphi Ventures
,
Solas BioVentures
Apr 1, 2015
Edge Therapeutics
$56.0M Series C
Anders Hove
1955 Capital
,
Aberdare Ventures
,
Acorn Bioventures
,
Founders Fund
,
Highbury Group
,
Lightspeed Venture Partners
,
OrbiMed
,
Sequoia Capital
,
Sofinnova Investments
, Ted Driscoll
, Franklin Templeton
, Janus Henderson Investors
,
New Leaf Venture Partners
Feb 1, 2015
Laguna Pharmaceuticals
$30.0M Series B
Frazier Healthcare Partners
,
Versant Ventures
Bessemer Venture Partners
,
Third Rock Ventures
, Sante Ventures
Sep 1, 2014
TRACON Pharmaceuticals
$27.0M Series B
—
New Enterprise Associates
,
Arcus Ventures
, BHP Ventures
, Bruce D. Steel
,
Brookline Investments
, Jafco Ventures
, Nextech Invest
Jan 8, 2014
Auspex Pharmaceuticals
$35.0M Debt / Series E
Jonathan Leff
CMEA Capital
,
Costa Verde Capital
,
Oxford Finance
,
Panorama Capital
, Thomas, McNerney & Partners
Dec 1, 2012
NanoString Technologies
$15.0M Series E
—
GE Ventures
, Henri Termeer
,
AllianceBernstein
,
Clarus Ventures
, Draper Fisher Jurvetson
,
GE
, Morgan Stanley
,
OVP Venture Partners
Nov 7, 2011
NanoString Technologies
$20.0M Series D
—
Henri Termeer
,
Clarus Ventures
, Draper Fisher Jurvetson
, Pascale Witz
,
OVP Venture Partners